0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Articles   |    
Genome-Wide Association Study of Suicide Attempts in Mood Disorder Patients
Roy H. Perlis, M.D., M.Sc.; Jie Huang, M.D., M.S., M.P.H.; Shaun Purcell, Ph.D.; Maurizio Fava, M.D.; A. John Rush, M.D.; Patrick F. Sullivan, M.D.; Steven P. Hamilton, M.D., Ph.D.; Francis J. McMahon, M.D.; Thomas Schulze, M.D.; James B. Potash, M.D., M.P.H.; Peter P. Zandi, Ph.D.; Virginia L. Willour, Ph.D.; Brenda W. Penninx, Ph.D., M.D.; Dorret I. Boomsma, Ph.D.; Nicole Vogelzangs, Ph.D.; Christel M. Middeldorp, M.D., Ph.D.; Marcella Rietschel, M.D.; Markus Nöthen, Ph.D.; Sven Cichon, Ph.D.; Hugh Gurling, M.D., M.Phil.; Nick Bass, M.D.; Andrew McQuillin, Ph.D.; Marian Hamshere, Ph.D.; ; Nick Craddock, M.D., Ph.D.; Pamela Sklar, M.D., Ph.D.; Jordan W. Smoller, M.D., Sc.D.
Am J Psychiatry 2010;167:1499-1507. doi:10.1176/appi.ajp.2010.10040541
View Author and Article Information
From the Department of Psychiatry, Depression and Bipolar Clinic and Research Programs, Massachusetts General Hospital, Boston; the Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetics Research, Massachusetts General Hospital, Boston; the Duke-National University of Singapore Graduate Medical School, Singapore; the Departments of Genetics, Psychiatry, and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, N.C.; the University of California at San Francisco, San Francisco; the Genetic Basis of Mood and Anxiety Disorders Division, National Institute of Mental Health, Bethesda, Md.; the Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore; the Departments of Psychiatry and Biological Psychology, Vrije Universiteit University Medical Center, Amsterdam; the Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, University of Heidelberg, Heidelberg, Germany; the Department of Psychiatry and Institute of Human Genetics, University of Bonn, Bonn, Germany; the Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany; the Institute of Neuroscience and Medicine (INM-1), Research Center Juelich, Juelich, Germany; the Department of Molecular Psychiatry, University College London Medical School, London; and the Department of Psychological Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

This article is discussed in an editorial by Drs. Uher and Perroud (p. 1425)

Received April 13, 2010; revision received June 22, 2010; accepted July 15, 2010.

Dr. Perlis has received research support from Eli Lilly and Elan/Eisai; he has received advisory/consulting fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Pfizer; he has received speaking fees or honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo-SmithKline, and Pfizer; and he has equity holdings and patents with Concordant Rater Systems. Dr. Fava has received research support from Abbott Laboratories, Alkermes, Aspect Medical Systems, Astra-Zeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Pharmaceuticals, GlaxoSmithKline, J and J Pharmaceuticals, Lichtwer Pharma GmbH, Lorex Pharmaceuticals, Novartis, Organon, Pamlab, Pfizer, Pharmavite, Roche, Sanofi/Synthelabo, Solvay Pharmaceuticals, and Wyeth-Ayerst Laboratories; he has received advisory/consulting fees from Aspect Medical Systems, AstraZeneca, Bayer AG, Biovail Pharmaceuticals, BrainCells, Bristol-Myers Squibb, Cephalon, Compellis, Cypress Pharmaceuticals, Dov Pharmaceuticals, Eli Lilly, EPIX Pharmaceuticals, Fabre-Kramer Pharmaceuticals, Forest Pharmaceuticals, GlaxoSmithKline, Grunenthal GmbH, Janssen Pharmaceutica, Jazz Pharmaceuticals, J and J Pharmaceuticals, Knoll Pharmaceutical, Lundbeck, MedAvante, Neuronetics, Novartis, Nutrition 21, Organon, Pamlab, Pfizer, PharmaStar, Pharmavite, Roche, Sanofi/ Synthelabo, Sepracor, Solvay Pharmaceuticals, Somaxon, Somerset Pharmaceuticals, and Wyeth-Ayerst Laboratories; he has received speaking fees from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Pharmaceuticals, GlaxoSmith-Kline, Novartis, Organon, Pfizer, PharmaStar, and Wyeth-Ayerst Laboratories; and he is a share holder with Compellis and MedAvante. Dr. Rush has served as a consultant for AstraZeneca, Bristol-Myers Squibb/Otsuka, Merck, and Otsuka Pharmaceuticals; he has also received royalties from Guilford Publications and Healthcare Technology Systems. Dr. Smoller has served as a consultant to Eli Lilly; he has received honoraria from Hoffman-La Roche, Enterprise Analysis, and MPM Capital; and he has served on an advisory board for Roche Diagnostics Corporation. Dr Sullivan receives unrestricted research funding from Eli Lilly for genetic research in schizophrenia. All other authors report no financial relationships with commercial interests.

Supported by National Institute of Mental Health grant R01MH-086026 (Dr. Perlis). Drs. McMahon and Schulze are supported by the NIMH Intramural Research Program.

Address correspondence and reprint requests to Dr. Perlis, Bipolar Clinic and Research Program, Massachusetts General Hospital, 50 Staniford St., Suite 580 Boston, MA 02114; rperlis@partners.org (e-mail).

Received April 13, 2010; Revised June 22, 2010; Accepted July 15, 2010.

Copyright © American Psychiatric Association

Abstract

Objective:  Family and twin studies suggest that liability for suicide attempts is heritable and distinct from mood disorder susceptibility. The authors therefore examined the association between common genomewide variation and lifetime suicide attempts.

Method:  The authors analyzed data on lifetime suicide attempts from genomewide association studies of bipolar I and II disorder as well as major depressive disorder. Bipolar disorder subjects were drawn from the Systematic Treatment Enhancement Program for Bipolar Disorder cohort, the Wellcome Trust Case Control Consortium bipolar cohort, and the University College London cohort. Replication was pursued in the NIMH Genetic Association Information Network bipolar disorder project and a German clinical cohort. Depression subjects were drawn from the Sequential Treatment Alternatives to Relieve Depression cohort, with replication in the Netherlands Study of Depression and Anxiety/Netherlands Twin Register depression cohort.

Results:  Strongest evidence of association for suicide attempt in bipolar disorder was observed in a region without identified genes (rs1466846); five loci also showed suggestive evidence of association. In major depression, strongest evidence of association was observed for a single nucleotide polymorphism in ABI3BP, with six loci also showing suggestive association. Replication cohorts did not provide further support for these loci. However, meta-analysis incorporating approximately 8,700 mood disorder subjects identified four additional regions that met the threshold for suggestive association, including the locus containing the gene coding for protein kinase C-epsilon, previously implicated in models of mood and anxiety.

Conclusions:  The results suggest that inherited risk for suicide among mood disorder patients is unlikely to be the result of individual common variants of large effect. They nonetheless provide suggestive evidence for multiple loci, which merit further investigation.

Abstract Teaser
Figures in this Article

Epidemiologic studies indicate that mood disorders are associated with a marked increase in risk for suicide and suicide attempts, with one such study suggesting a 20-fold greater risk of death from suicide compared with the general population (1). The familiality of suicide risk is well-established (for a review, see Brodsky et al. [2]) and not accounted for solely by familial transmission of mood disorders (35). For example, a family-based study of a large, bipolar disorder cohort suggested that lifetime suicide attempts were among the more strongly familial features of the disorder (6). That risk for suicide attempt in particular is heritable is supported by twin studies (7, 8), with heritability estimates ranging from 30%—50%, intermediate between major depressive disorder and bipolar disorder. Adoption studies suggest that this risk cannot be explained solely by shared environment (9).

Individual candidate-gene studies have implicated genes of the serotonergic or noradrenergic system (1014), hypothalamic-pituitary-adrenal axis (15, 16), renin-angiotensin system (17), and neuronal development (1820) and function (21) in the propensity for suicide, using a variety of case and control definitions (for a review, see Brezo et al. [22]). However, given the limited understanding of pathophysiology, prioritizing candidates for study has been difficult and likely accounts for the near absence of consistent replication. The emergence of low-cost approaches for characterizing common genetic variation across the genome facilitates an alternate approach, which may lead to identification of truly novel risk factors, as has been the case in nonpsychiatric disorders (23).

Therefore, we analyzed data from multiple genome-wide association studies to identify variations associated with suicide risk. To minimize the potential heterogeneity introduced by pooling mood disorder subjects, cohorts with bipolar disorder and major depression were examined separately and then combined for meta-analysis. In all, data from >8,700 mood disorder subjects were used to detect and replicate associations.

+

Study Design, Genotyping, Quality Control, and Imputation

The cohorts examined in the present study are summarized in Table 1. For bipolar disorder, genomewide association data were derived from three nonoverlapping cohorts of bipolar I or II patients, all of which were included in a previously reported meta-analysis of disease liability (24). These bipolar disorder cohorts were from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) (25, 26), the Wellcome Trust Case Control Consortium (27), and the University College London. Details of sample ascertainment and genotyping have been previously described by Ferreira et al. (24). Quality control and imputation using MACH (28) are described in the original reports (summarized in the data supplement accompanying the online version of this article), yielding 1,922,309 single nucleotide polymorphisms (SNPs) in 3,117 subjects.

 
Anchor for Jump
TABLE 1.

Mood Disorder Cohorts Included in Suicide Attempt Analyses

Follow-up analyses examined the most significant SNPs from these cohorts in pooled data from the following three additional bipolar disorder cohorts: the initial Genetic Association Information Network (GAIN) bipolar disorder project and the Translational Genomics Research Institute samples (29), both drawn from the five waves of sample collection in the NIMH Bipolar Disorder Genetics Initiative (30), and a sample of German individuals collected at the Universities of Bonn and Heidelberg (31). Genotyping, quality control, and imputation are described by Smith et al. (29) and McMahon et al. (31).

Table 1 also lists the major depression cohorts included in primary and replication analyses, which were the Systematic Treatment Alternatives to Relieve Depression (STAR*D) cohort (32) and the GAIN depression cohort that was derived from the Netherlands Study of Depression and Anxiety (33)/Netherlands Twin Register (34) cohorts (35). The former data set was used in initial analyses, with replication pursued in the latter. Details of genotyping and quality control for the STAR*D cohort have been previously described by Garriock et al. (36) (for additional quality control steps and imputation using MACH, see the data supplement), yielding 1,954,455 SNPs in 1,273 subjects. For the Netherlands Study of Depression and Anxiety/Netherlands Twin Register, methods are described by Sullivan et al. (35). Imputation was performed using IMPUTE (http://mathgen.stats.ox.ac.uk/impute/impute.html), with a threshold of 70% confidence.

+

Identification of Lifetime Suicide Attempts

For the STEP-BD cohort, determination of lifetime suicide attempts was conducted using all available sources of information, including the Affective Disorders Evaluation (37), which incorporates questions from the Structured Clinical Interview for DSM-IV Axis I Disorders (38) at study entry, as well as data regarding suicide attempt during the study period documented as serious adverse effect or hospitalization. In the Wellcome Trust Case Control Consortium, lifetime suicide attempts were identified with a semistructured diagnostic psychiatric interview. Assessment of the University College London cohort was conducted utilizing the Schedule for Affective Disorders and Schizophrenia-Lifetime version (39), which includes questions about the presence or absence of lifetime suicide attempt. Among the replication cohorts, the GAIN and Translational Genomics Research Institute samples were assessed using the Diagnostic Interview for Genetic Studies (40), which includes questions regarding lifetime suicide attempt. Assessment of the German university cohorts also incorporated structured interview and review of psychiatric history.

In the STAR*D cohort, lifetime history of suicide attempts was assessed at the initial study visit by the study clinician (41); suicidality was not exclusionary, provided the patient did not require hospitalization for stabilization. Finally, lifetime suicide attempt in the Netherlands Study of Depression and Anxiety/Netherlands Twin Register group was determined at diagnostic interview, which included the Composite International Diagnostic Interview, version 2.1 (42).

+

Analysis

Primary analyses were performed with logistic regression of the presence or absence of suicide attempt on single SNP allelic dosage, adjusted for the first four components from the aforementioned multidimensional scaling plot, to address the possibility of confounding by population substructure. Analyses were conducted using PLINK, version 1.07 (43). Results were not meaningfully different with inclusion of the first 10 indices of ancestry.

The bipolar disorder and major depression cohorts were initially analyzed independently as discovery data sets, based on the hypothesis that suicide susceptibility could be diagnosis-specific so that pooling across mood disorders would increase heterogeneity and diminish power to detect association. All available data sets were initially pooled, rather than holding some out to allow for a replication cohort. Therefore, to examine suicide liability among patients diagnosed with bipolar disorder, combined data from the STEP-BD, Wellcome Trust Case Control Consortium, and University College London cohorts were analyzed jointly. For replication, any SNP with a p value <1×10−3 in this combined cohort was then examined in the combined GAIN, Translational Genomics Research Institute, and German cohorts. In parallel, STAR*D data were analyzed for association with suicide attempts among individuals with major depression. For replication, any SNP associated with a p value <1×10−3 was then examined in the Netherlands Study of Depression and Anxiety/Netherlands Twin Register cohorts. Power to detect association at the nominal threshold for replication (p<1×10−3) in the bipolar discovery cohort was >95% for a minor allele frequency of 20% and genotypic risk ratio of 1.25, corresponding to a genotypic odds ratio of approximately 1.36. For depression, power under the same conditions decreased to 33%.

Finally, to examine the hypothesis that suicide liability arises from variation common to depression and bipolar disorder, random effects meta-analysis was used to examine any SNP implicated in either bipolar disorder or depression with a p value <1×10−3 across all mood disorder subjects, using PLINK. For the combined cohorts, power was >90% to detect association at a p value <5×10−8 for a minor allele frequency of 20% and genotypic risk ratio of 1.2, which in the present study corresponds to a genotypic odds ratio of approximately 1.3.

For descriptive purposes, a set of candidate genes was identified based upon previous reports of association. Candidates were selected based on a MEDLINE search, performed in June 2010, using the terms "suicide," "genetic," and "association," followed by manual review of abstracts under the name of the corresponding author of the articles identified. Any gene with at least one report of significant association with suicide attempt was included, even if such association was identified only in a subset of subjects. This search yielded 19 regions. We performed gene-based tests by combining the single-SNP p values, using a weighted-inverse chi-square method that accounts for correlation between tests (44), implemented in PLINK. We used the correlation between alleles (i.e., linkage disequilibrium) in the Caucasian-European (Centre d'Etude du Polymorphisme Humain from Utah) phase II HapMap project to estimate the correlation between tests, which performed well in simulation experiments. For descriptive purposes, the minimum p value for any SNP within the gene or 20-kb flanking regions was also identified.

In the bipolar disorder cohort, 1,295 out of 3,117 subjects (41.5%) reported a history of suicide attempts. Figures 1 and 2 in the data supplement show Q-Q and Manhattan plots for suicide attempts in this cohort (λ=1.003). A total of five loci included SNPs with a p value <1×610−5; the minimum p value was 1.98×10−6 (rs1466846, with no known gene within 400 kb) (Table 2 [also see Table 1 in the data supplement]). None of these loci yielded a nominal p value <0.05 in the bipolar disorder replication cohort, which included 2,698 subjects, of whom 1,201 (44.5%) reported a lifetime history of suicide attempts.

 
Anchor for Jump
TABLE 2.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Bipolar Disorder Discovery Cohort

Among 1,273 subjects with major depression, 176 (9.9%) reported a history of suicide attempts. Q-Q and Manhattan plots for this cohort are presented in Figure 3 and Figure 4 in the data supplement (λ=1.017). A total of six loci included SNPs with a p value <1×10−5; the minimum p value was 2.55×10−8 (rs2576377 in gene ABI3BP) (Table 3 [also see Table 2 in the data supplement]). However, none of these regions yielded a p value <0.05 in a second depression cohort of 1,649 subjects, including 133 individuals (8.1%) with a history of suicide attempts.

 
Anchor for Jump
TABLE 3.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Major Depressive Disorder Discovery Cohort

We also examined association results in 19 genes previously suggested to be associated with suicide attempts in at least one prior report. Table 4 lists the results of a gene-based test for association, which accounts for correlation between tests (SNPs) within a gene. Two genes, FKBP5 and NGFR (p75NTR), showed nominal evidence of association in bipolar disorder subjects (uncorrected p<0.05) but did not survive correction for 19 comparisons (see Table 4 in the data supplement). Minimum single-SNP p values for each gene (with 20-kb flanking regions) are presented in the data supplement.

 
Anchor for Jump
TABLE 4.

Gene-Based Tests of Association for 19 Candidate Loci

Lastly, we examined any SNP with a p value <1×10−3 in either the major depression or bipolar disorder discovery cohort, using random-effects meta-analysis across all available mood disorder subjects (N=8,737). None of the aforementioned loci identified were more strongly implicated by meta-analysis. Table 5 shows all SNPs with a p value <1×10−5 in the overall meta-analysis (complete results are shown in Table 3 of the data supplement). The 10 SNPs that met this threshold are in four loci, including SNPs in genes coding for sorbin and SH3-domain containing-1 (SORBS1) and protein kinase C-epsilon (PRKCE).

 
Anchor for Jump
TABLE 5.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Meta-Analysis of All Mood Disorder Subjects

We examined and then attempted to replicate associations with suicide attempt liability among a total of approximately 2,900 subjects with major depression and approximately 5,800 subjects with bipolar disorder. One region, with multiple intronic SNPs in Abl-interactor family member 3 binding protein (ABI3BP or TARSH) (45), met our threshold for genomewide significance in suicide attempt liability among individuals with depression but failed to replicate in a second cohort. This gene is known to be expressed in brain as well as multiple other organ systems, but its function is not well-characterized, although it may have effects in apoptosis and senescence (4648). While the most likely explanation for this nonreplication remains a type I error, we also note that heterogeneity between STAR*D and the Netherlands Study of Depression and Anxiety/Netherlands Twin Register has been suggested as another explanation for nonreplication of significant associations with variants in the Piccolo (PCLO) region in depression liability (35). Other regions with suggestive evidence of association in depression include SLC4A4, coding for a sodium bicarbonate cotransporter, which is also widely expressed (and believed to interact with inositol tri-phosphate signaling [49]); hyaluronan synthase-1 (HAS1), important in synthesis of extracellular matrix and brain inflammatory response (50, 51); adenosine diphosphateribosylation factor-like-6-interacting protein-2 (ARL6IP2), whose expression is influenced by nitric oxide signaling (52); and the putative leucine-rich repeat-containing protein 44 (LRRC44 or LRRIQ3) (53).

Among the most regions with the greatest evidence of association in bipolar disorder were the transducin beta-like receptor 1 (TBL1XR1), implicated in gene activation by nuclear receptors (for example, based upon presence in histone deacetylase-3 (HDAC3) complexes [54]); Iroquois homeobox protein 2 (IRX2), important in embryonic pattern formation, including brain development (55); and calpain-13 (CAPN13), part of a class of cysteine proteases with multiple functions, including synaptic plasticity (56). Once again, no single SNP showed evidence of replication in a second cohort. Examination of candidate regions using a gene-based test provided modest support for two loci, FKBP5 and NGFR (p75NTR), identified in previous investigations of suicide attempt (19, 20), although neither results survived correction for the 19 tests performed.

Meta-analysis of association data across mood disorders did not provide further support for the novel loci identified in the discovery cohorts. However, SNPs in two genes were associated with a p value <1×10−5. The first, SORBS1, has been implicated in insulin signaling (57); its product was also shown to interact with ataxin-7, the site of a trinucleo-tide repeat causing spinocerebellar atrophy type 7 (58). The second, PRKCE, is most notable because PRKCE null mice have been shown to exhibit reduced anxiety behavior and lower levels of multiple stress hormones, with increased sensitivity to neurosteroids that modulate gamma-aminobutyric acid type A receptors (59). A recent postmortem study found differences in expression of multiple protein kinases, including PRKCE, in individuals with depression relative to comparison subjects (60). Overall, this examination of approximately 8,700 mood disorder subjects may provide a framework for considering future association results.

While our results provide some support for multiple novel regions of potential interest, they also suggest that individual common variants of large effect are unlikely to account for the known heritability of suicide risk, leading to the problem of missing heritability. A recent review described multiple potential explanations for the observed paucity of common variants of large effect, noting the potential importance of epistatic or epigenetic effects, for example, among many others (61). Notably, the absence of large effects also does not preclude SNPs in aggregate accounting for a substantial proportion of disease risk, which may be the case in schizophrenia, for example (62). However, it also bears consideration that suicide liability should detract from reproductive fitness, with the pressure of purifying selection acting to keep risk variants rare, which might argue for more aggressive pursuit of rare variants (61).

Several features of our analytic approach bear consideration. We prioritized a within-disorder analysis to minimize the potential heterogeneity introduced by combining mood disorder subjects in the absence of strong evidence of cross-disorder risk. Pooling both disorders could have improved our power to detect association but at the cost of reducing power because of heterogeneity. Similarly, while we initially analyzed all samples available to us (rather than holding some out in order to allow for replication), we were later able to identify replication data sets, but not to fully pool results. Thus, the final design included discovery followed by replication. We pursued a replication-discovery design.

We elected to assess the harder endpoint of suicide attempt rather than lifetime suicidal ideation for two reasons. First, the latter is difficult to assess retrospectively, while recall and other biases are less likely to impact reporting of suicide attempt, particularly where sources of collateral information, such as emergency room visits or hospital discharge summaries, are available. Retrospective suicidal ideation was not assessed in STEP-BD or STAR-D. Second, twin studies suggest that while much of the heritability of thoughts of suicide may be accounted for by familial transmission of disease liability, risk for suicidal behavior may be more distinctly heritable (2).

An important caveat in considering these results is that lifetime suicide attempt was not the primary phenotype of interest in these cohorts and was assessed by one or a few items on a scale. Thus, it is likely that suicide attempt was underreported in these cohorts, which would lead to misclassification error and diminish our power to detect association. In addition, while many mood disorder subjects make a suicide attempt early in their illness course, we cannot exclude the possibility that some subjects labeled as nonattempters would ultimately go on to make an attempt, leading to further misclassification.

Also of note, to minimize type I error, we did not consider any subphenotypes. Investigations of suicide often focus on the nature of the suicide attempt, in terms of degree of aggression or violence involved; more violent or more potentially lethal attempts have been suggested to represent a subgroup with greater homogeneity (63). However, the majority of cohorts examined in the present study did not distinguish this phenotype. We also did not conduct sex-stratified analyses. While suicidal behavior may differ by sex, we could not identify a strong rationale for positing sex differences in heritability and were mindful of the hazards of this sort of subanalysis (64).

Some prior investigations of suicide have compared suicide attempters with healthy comparison subjects. In the present study, we elected instead to contrast attempters with nonattempters among a single disorder, which allowed us to distinguish genes conferring suicide risk beyond that conferred by the disorder itself. That is, rather than a case-control association study of the putative subtype of bipolar-plus-suicide attempt, we focused on suicide liability per se.

Taken together, our results suggest an absence of common variants of large effect mediating suicide liability in mood disorders. A recent investigation of bipolar disorder and schizophrenia liability suggested that a substantial portion of risk for these disorders may be highly polygenic (62). The observation of an excess of SNPs with p values approximately <1×10−3, apparent in both Q-Q plots but particularly in that of the depression cohort, would be consistent with this model. For the effect sizes observed in our meta-analysis (i.e., odds ratio of approximately 1.2), approximately 7,000 suicide attempt cases (with matched nonattempting comparison subjects) would be required for 80% power to identify SNPs with a minor allele frequency of 20% and a p value <5×610−8. Thus, analysis of even larger cohorts, in the context of consortia such as the Psychiatric Genomewide Association Study Consortium (65), and consideration of alternate models of heritability—for example, using polygenic models or considering rarer variants of larger effect—may be required to identify loci that confer risk for suicide in mood disorders.

The authors thank the patients who participated in the genetic studies summarized in this article, including participants in STEP-BD, the Wellcome Trust Case Control Consortium, the University College London, the Genetic Association Information Network, the Translational Genomics Research Institute, and the Netherlands Study of Depression and Anxiety/Netherlands Twin Register.

Osby  U;  Brandt  L;  Correia  N;  Ekbom  A;  Sparen  P:  Excess mortality in bipolar and unipolar disorder in Sweden.  Arch Gen Psychiatry 2001; 58:844—850
[CrossRef] | [PubMed]
 
Brodsky  BS;  Mann  JJ;  Stanley  B;  Tin  A;  Oquendo  M;  Birmaher  B;  Greenhill  L;  Kolko  D;  Zelazny  J;  Burke  AK;  Melhem  NM;  Brent  D:  Familial transmission of suicidal behavior: factors mediating the relationship between childhood abuse and offspring suicide attempts.  J Clin Psychiatry 2008; 69:584—596
[CrossRef] | [PubMed]
 
Brent  DA;  Bridge  J;  Johnson  BA;  Connolly  J:  Suicidal behavior runs in families: a controlled family study of adolescent suicide victims.  Arch Gen Psychiatry 1996; 53:1145—1152
[PubMed]
[CrossRef]
 
Johnson  BA;  Brent  DA;  Bridge  J;  Connolly  J:  The familial aggregation of adolescent suicide attempts.  Acta Psychiatr Scand 1998; 97:18—24
[CrossRef] | [PubMed]
 
Cheng  AT;  Chen  TH;  Chen  CC;  Jenkins  R:  Psychosocial and psychiatric risk factors for suicide: case-control psychological autopsy study.  Br J Psychiatry 2000; 177:360—365
[CrossRef] | [PubMed]
 
Schulze  TG;  Hedeker  D;  Zandi  P;  Rietschel  M;  McMahon  FJ:  What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics.  Arch Gen Psychiatry 2006; 63:1368—1376
[CrossRef] | [PubMed]
 
Fu  Q;  Heath  AC;  Bucholz  KK;  Nelson  EC;  Glowinski  AL;  Goldberg  J;  Lyons  MJ;  Tsuang  MT;  Jacob  T;  True  MR;  Eisen  SA:  A twin study of genetic and environmental influences on suicidality in men.  Psychol Med 2002; 32:11—24
[CrossRef] | [PubMed]
 
Statham  DJ;  Heath  AC;  Madden  PA;  Bucholz  KK;  Bierut  L;  Dinwiddie  SH;  Slutske  WS;  Dunne  MP;  Martin  NG:  Suicidal behaviour: an epidemiological and genetic study.  Psychol Med 1998; 28:839—855
[CrossRef] | [PubMed]
 
Wender  PH;  Kety  SS;  Rosenthal  D;  Schulsinger  F;  Ortmann  J;  Lunde  I:  Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders.  Arch Gen Psychiatry 1986; 43:923—929
[PubMed]
[CrossRef]
 
Liu  X;  Li  H;  Qin  W;  He  G;  Li  D;  Shen  Y;  Shen  J;  Gu  N;  Feng  G;  He  L:  Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population.  J Med Genet 2006; 43:e4
[CrossRef] | [PubMed]
 
Fukutake  M;  Hishimoto  A;  Nishiguchi  N;  Nushida  H;  Ueno  Y;  Shirakawa  O;  Maeda  K:  Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females.  Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1428—1433
[CrossRef] | [PubMed]
 
Yoon  HK;  Kim  YK:  TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.  Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:403—409
[CrossRef] | [PubMed]
 
Bonnier  B;  Gorwood  P;  Hamon  M;  Sarfati  Y;  Boni  C;  Hardy-Bayle  MC:  Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk.  Biol Psychiatry 2002; 51:762—765
[CrossRef] | [PubMed]
 
Neves  FS;  Silveira  G;  Romano-Silva  MA;  Malloy-Diniz  L;  Ferreira  AA;  De Marco  L;  Correa  H:  Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients? Am J Med Genet B Neuropsychiatr Genet 2008; 147B:114—116
[CrossRef] | [PubMed]
 
Wasserman  D;  Wasserman  J;  Rozanov  V;  Sokolowski  M:  Depression in suicidal males: genetic risk variants in the CRHR1 gene.  Genes Brain Behav 2009; 8:72—79
[CrossRef] | [PubMed]
 
Willour  VL;  Chen  H;  Toolan  J;  Belmonte  P;  Cutler  DJ;  Goes  FS;  Zandi  PP;  Lee  RS;  MacKinnon  DF;  Mondimore  FM;  Schweizer  B;  Bipolar Disorder Phenome GroupNIMH Genetics Initiative Bipolar Disorder Consortium;  DePaulo  JR  Jr;  Gershon  ES;  McMahon  FJ;  Potash  JB:  Family-based association of FKBP5 in bipolar disorder.  Mol Psychiatry 2009; 14:261—268
[CrossRef] | [PubMed]
 
Sparks  DL;  Hunsaker  JC  3rd;  Amouyel  P;  Malafosse  A;  Bellivier  F;  Leboyer  M;  Courtet  P;  Helbecque  N:  Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors.  Am J Med Genet B Neuropsychiatr Genet 2009; 150B:290—294
[CrossRef] | [PubMed]
 
Must  A;  Tasa  G;  Lang  A;  Vasar  E;  Koks  S;  Maron  E;  Väli  M:  Association of limbic system-associated membrane protein (LSAMP) to male completed suicide.  BMC Med Genet 2008; 9:34
[CrossRef] | [PubMed]
 
Kohli  MA;  Salyakina  D;  Pfennig  A;  Lucae  S;  Horstmann  S;  Menke  A;  Kloiber  S;  Hennings  J;  Bradley  BB;  Ressler  KJ;  Uhr  M;  Müller-Myhsok  B;  Holsboer  F;  Binder  EB:  Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.  Arch Gen Psychiatry 2010; 67:348—359
[CrossRef] | [PubMed]
 
Kunugi  H;  Hashimoto  R;  Yoshida  M;  Tatsumi  M;  Kamijima  K:  A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide.  Am J Med Genet B Neuropsychiatr Genet 2004; 129B:44—46
[CrossRef] | [PubMed]
 
Lesch  KP;  Zeng  Y;  Reif  A;  Gutknecht  L:  Anxiety-related traits in mice with modified genes of the serotonergic pathway.  Eur J Pharmacol 2003; 480:185—204
[CrossRef] | [PubMed]
 
Brezo  J;  Klempan  T;  Turecki  G:  The genetics of suicide: a critical review of molecular studies.  Psychiatr Clin North Am 2008; 31:179—203
[CrossRef] | [PubMed]
 
Altshuler  D;  Daly  M:  Guilt beyond a reasonable doubt.  Nat Genet 2007; 39:813—815
[CrossRef] | [PubMed]
 
Ferreira  MA;  O'Donovan  MC;  Meng  YA;  Jones  IR;  Ruderfer  DM;  Jones  L;  Fan  J;  Kirov  G;  Perlis  RH;  Green  EK;  Smoller  JW;  Grozeva  D;  Stone  J;  Nikolov  I;  Chambert  K;  Hamshere  ML;  Nimgaonkar  VL;  Moskvina  V;  Thase  ME;  Caesar  S;  Sachs  GS;  Franklin  J;  Gordon-Smith  K;  Ardlie  KG;  Gabriel  SB;  Fraser  C;  Blumenstiel  B;  Defelice  M;  Breen  G;  Gill  M;  Morris  DW;  Elkin  A;  Muir  WJ;  Mc-Ghee  KA;  Williamson  R;  MacIntyre  DJ;  MacLean  AW;  Clair  D  St;  Robinson  M;  Van Beck  M;  Pereira  AC;  Kandaswamy  R;  McQuillin  A;  Collier  DA;  Bass  NJ;  Young  AH;  Lawrence  J;  Ferrier  IN;  Anjorin  A;  Farmer  A;  Curtis  D;  Scolnick  EM;  McGuffin  P;  Daly  MJ;  Corvin  AP;  Holmans  PA;  Blackwood  DH;  Gurling  HM;  Owen  MJ;  Purcell  SM;  Sklar  P;  Craddock  N; Wellcome Trust Case Control Consortium:  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.  Nat Genet 2008; 40:1056—1058
[CrossRef] | [PubMed]
 
Sachs  GS;  Thase  ME;  Otto  MW;  Bauer  M;  Miklowitz  D;  Wisniewski  SR;  Lavori  P;  Lebowitz  B;  Rudorfer  M;  Frank  E;  Nierenberg  AA;  Fava  M;  Bowden  C;  Ketter  T;  Marangell  L;  Calabrese  J;  Kupfer  D;  Rosenbaum  JF:  Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).  Biol Psychiatry 2003; 53:1028—1042
[CrossRef] | [PubMed]
 
Perlis  RH;  Ostacher  MJ;  Patel  JK;  Marangell  LB;  Zhang  H;  Wisniewski  SR;  Ketter  TA;  Miklowitz  DJ;  Otto  MW;  Gyulai  L;  Reilly-Harrington  NA;  Nierenberg  AA;  Sachs  GS;  Thase  ME:  Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar disorder (STEP-BD).  Am J Psychiatry 2006; 163:217—224
[CrossRef] | [PubMed]
 
Wellcome Trust Case Control Consortium:  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.  Nature 2007; 447:661—678
[CrossRef] | [PubMed]
 
Li  Y;  Abecasis  G:  MACH 1.0:  Rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet 2006; S79:2290
 
Smith  EN;  Bloss  CS;  Badner  JA;  Barrett  T;  Belmonte  PL;  Berrettini  W;  Byerley  W;  Coryell  W;  Craig  D;  Edenberg  HJ;  Eskin  E;  Foroud  T;  Gershon  E;  Greenwood  TA;  Hipolito  M;  Koller  DL;  Lawson  WB;  Liu  C;  Lohoff  F;  McInnis  MG;  McMahon  FJ;  Mirel  DB;  Murray  SS;  Nievergelt  C;  Nurnberger  J;  Nwulia  EA;  Paschall  J;  Potash  JB;  Rice  J;  Schulze  TG;  Scheftner  W;  Panganiban  C;  Zaitlen  N;  Zandi  PP;  Zöllner  S;  Schork  NJ;  Kelsoe  JR:  Genome-wide association study of bipolar disorder in European American and African American individuals.  Mol Psychiatry 2009; 14:755—763
[CrossRef] | [PubMed]
 
NIMH Genetics Bipolar Group:  Genomic survey of bipolar illness in the NIMH Genetics Initiative pedigrees: a preliminary report.  Am J Med Genet 1997; 74:227—237
[CrossRef] | [PubMed]
 
McMahon  FJ;  Akula  N;  Schulze  TG;  Muglia  P;  Tozzi  F;  Detera-Wadleigh  SD;  Steele  CJ;  Breuer  R;  Strohmaier  J;  Wendland  JR;  Mattheisen  M;  Mühleisen  TW;  Maier  W;  Nöthen  MM;  Cichon  S;  Farmer  A;  Vincent  JB;  Holsboer  F;  Preisig  M;  Rietschel  M; Bipolar Disorder Genome Study Consortium:  Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.  Nat Genet 2010; 42:128—131
[CrossRef] | [PubMed]
 
Rush  AJ;  Fava  M;  Wisniewski  SR;  Lavori  PW;  Trivedi  MH;  Sackeim  HA;  Thase  ME;  Nierenberg  AA;  Quitkin  FM;  Kashner  TM;  Kupfer  DJ;  Rosenbaum  JF;  Alpert  J;  Stewart  JW;  McGrath  PJ;  Biggs  MM;  Shores-Wilson  K;  Lebowitz  BD;  Ritz  L;  Niederehe  G; STAR*D Investigators Group:  Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design.  Control Clin Trials 2004; 25:119—142
[CrossRef] | [PubMed]
 
Penninx  BW;  Beekman  AT;  Smit  JH;  Zitman  FG;  Nolen  WA;  Spin-hoven  P;  Cuijpers  P;  De Jong  PJ;  Van Marwijk  HW;  Assendelft  WJ;  Van Der Meer  K;  Verhaak  P;  Wensing  M;  De Graaf  R;  Hoogendijk  WJ;  Ormel  J;  Van Dyck  R; NESDA Research Consortium:  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.  Int J Methods Psychiatr Res 2008; 17:121—140
[CrossRef] | [PubMed]
 
Boomsma  DI;  de Geus  EJ;  Vink  JM;  Stubbe  JH;  Distel  MA;  Hottenga  JJ;  Posthuma  D;  van Beijsterveldt  TC;  Hudziak  JJ;  Bartels  M;  Willemsen  G:  Netherlands Twin Register: from twins to twin families.  Twin Res Hum Genet 2006; 9:849—857
[CrossRef] | [PubMed]
 
Sullivan  PF;  de Geus  EJ;  Willemsen  G;  James  MR;  Smit  JH;  Zand-belt  T;  Arolt  V;  Baune  BT;  Blackwood  D;  Cichon  S;  Coventry  WL;  Domschke  K;  Farmer  A;  Fava  M;  Gordon  SD;  He  Q;  Heath  AC;  Heutink  P;  Holsboer  F;  Hoogendijk  WJ;  Hottenga  JJ;  Hu  Y;  Kohli  M;  Lin  D;  Lucae  S;  MacIntyre  DJ;  Maier  W;  McGhee  KA;  McGuffin  P;  Montgomery  GW;  Muir  WJ;  Nolen  WA;  Nöthen  MM;  Perlis  RH;  Pirlo  K;  Posthuma  D;  Rietschel  M;  Rizzu  P;  Schosser  A;  Smit  AB;  Smoller  JW;  Tzeng  JY;  van Dyck  R;  Verhage  M;  Zitman  FG;  Martin  NG;  Wray  NR;  Boomsma  DI;  Penninx  BW:  Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.  Mol Psychiatry 2009; 14:359—375
[CrossRef] | [PubMed]
 
Garriock  HA;  Kraft  JB;  Shyn  SI;  Peters  EJ;  Yokoyama  JS;  Jenkins  GD;  Reinalda  MS;  Slager  SL;  McGrath  PJ;  Hamilton  SP:  A genomewide association study of citalopram response in major depressive disorder.  Biol Psychiatry 2010; 15:133—138
[CrossRef]
 
Sachs  GS;  Guille  C;  McMurrich  SL:  A clinical monitoring form for mood disorders.  Bipolar Disord 2002; 4:323—327
[CrossRef] | [PubMed]
 
First  MB;  Spitzer  R;  Gibbon  M:  Structured Clinical Interview for DSM-IV Axis I Disorders.  New York,  Biometrics Research Department, New York State Psychiatric Institute, 1996
 
Endicott  J;  Spitzer  RL:  A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia.  Arch Gen Psychiatry 1978; 35:837—844
[PubMed]
[CrossRef]
 
Nurnberger  JI  Jr;  Blehar  MC;  Kaufmann  CA;  York-Cooler  C;  Simpson  SG;  Harkavy-Friedman  J;  Severe  JB;  Malaspina  D;  Reich  T:  Diagnostic Interview for Genetic Studies: rationale, unique features, and training: NIMH Genetics Initiative.  Arch Gen Psychiatry 1994; 51:849—859; discussion 63-64
[PubMed]
[CrossRef]
 
Rush  AJ;  Trivedi  MH;  Ibrahim  HM;  Carmody  TJ;  Arnow  B;  Klein  DN;  Markowitz  JC;  Ninan  PT;  Kornstein  S;  Manber  R;  Thase  ME;  Kocsis  JH;  Keller  MB:  The 16-item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.  Biol Psychiatry 2003; 54:573—583
[CrossRef] | [PubMed]
 
World Health Organization:  Composite International Diagnostic Interview (CIDI), version 2.1.  Geneva, Switzerland,  World Health Organization, 1997
 
Purcell  S;  Neale  B;  Todd-Brown  K;  Thomas  L;  Ferreira  MA;  Bender  D;  Maller  J;  Sklar  P;  de Bakker  PI;  Daly  MJ;  Sham  PC:  PLINK: a tool set for whole-genome association and population-based linkage analyses.  Am J Hum Genet 2007; 81:559—575
[CrossRef] | [PubMed]
 
Makambi  KH:  Weighted inverse chi-square method for correlated significance tests.  J Appl Stat 2003; 30:225—234
[CrossRef]
 
Matsuda  S;  Iriyama  C;  Yokozaki  S;  Ichigotani  Y;  Shirafuji  N;  Yamaki  K;  Senba  M;  Uezato  H;  Ohshima  K;  Duc Dodon  M;  Wu  KJ;  Mori  N:  Cloning and sequencing of a novel human gene that encodes a putative target protein of NESH-SH3.  J Hum Genet 2001; 46:483—486
[CrossRef] | [PubMed]
 
Wakoh  T;  Sugimoto  M;  Terauchi  K;  Shimada  J;  Maruyama  M:  A novel p53-dependent apoptosis function of TARSH in tumor development.  Nagoya J Med Sci 2009; 71:109—114
[PubMed]
 
Latini  FR;  Hemerly  JP;  Oler  G;  Riggins  GJ;  Cerutti  JM:  Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.  Endocr Relat Cancer 2008; 15:787—799
[CrossRef] | [PubMed]
 
Uekawa  N;  Terauchi  K;  Nishikimi  A;  Shimada  J;  Maruyama  M:  Expression of TARSH gene in MEFS senescence and its potential implication in human lung cancer.  Biochem Biophys Res Commun 2005; 329:1031—1038
[CrossRef] | [PubMed]
 
Shirakabe  K;  Priori  G;  Yamada  H;  Ando  H;  Horita  S;  Fujita  T;  Fujimoto  I;  Mizutani  A;  Seki  G;  Mikoshiba  K:  IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na+/HCO3-cotransporter 1 (pNBC1).  Proc Natl Acad Sci U S A 2006; 103:9542—9547
[CrossRef] | [PubMed]
 
Itano  N;  Kimata  K:  Molecular cloning of human hyaluronan synthase.  Biochem Biophys Res Commun 1996; 222:816—820
[CrossRef] | [PubMed]
 
Al'Qteishat  A;  Gaffney  J;  Krupinski  J;  Rubio  F;  West  D;  Kumar  S;  Kumar  P;  Mitsios  N;  Slevin  M:  Changes in hyaluronan production and metabolism following ischaemic stroke in man.  Brain 2006; 129:2158—2176
[CrossRef] | [PubMed]
 
Turpaev  K;  Glatigny  A;  Bignon  J;  Delacroix  H;  Drapier  JC:  Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide.  Free Radic Biol Med 2010; 48:298—305
[CrossRef] | [PubMed]
 
Strausberg  RL;  Feingold  EA;  Grouse  LH;  Derge  JG;  Klausner  RD;  Collins  FS;  Wagner  L;  Shenmen  CM;  Schuler  GD;  Altschul  SF;  Zeeberg  B;  Buetow  KH;  Schaefer  CF;  Bhat  NK;  Hopkins  RF;  Jordan  H;  Moore  T;  Max  SI;  Wang  J;  Hsieh  F;  Diatchenko  L;  Marusina  K;  Farmer  AA;  Rubin  GM;  Hong  L;  Stapleton  M;  Soares  MB;  Bonaldo  MF;  Casavant  TL;  Scheetz  TE;  Brownstein  MJ;  Usdin  TB;  Toshiyuki  S;  Carninci  P;  Prange  C;  Raha  SS;  Loquellano  NA;  Peters  GJ;  Abramson  RD;  Mullahy  SJ;  Bosak  SA;  McEwan  PJ;  McKernan  KJ;  Malek  JA;  Gunaratne  PH;  Richards  S;  Worley  KC;  Hale  S;  Garcia  AM;  Gay  LJ;  Hulyk  SW;  Villalon  DK;  Muzny  DM;  Sodergren  EJ;  Lu  X;  Gibbs  RA;  Fahey  J;  Helton  E;  Ketteman  M;  Madan  A;  Rodrigues  S;  Sanchez  A;  Whiting  M;  Madan  A;  Young  AC;  Shevchenko  Y;  Bouffard  GG;  Blakesley  RW;  Touchman  JW;  Green  ED;  Dickson  MC;  Rodriguez  AC;  Grim-wood  J;  Schmutz  J;  Myers  RM;  Butterfield  YS;  Krzywinski  MI;  Skalska  U;  Smailus  DE;  Schnerch  A;  Schein  JE;  Jones  SJ;  Marra  MA; Mammalian Gene Collection Program Team:  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.  Proc Natl Acad Sci U S A 2002; 99:16899—16903
[CrossRef] | [PubMed]
 
Yoon  HG;  Chan  DW;  Huang  ZQ;  Li  J;  Fondell  JD;  Qin  J;  Wong  J:  Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.  EMBO J 2003; 22:1336—1346
[CrossRef] | [PubMed]
 
Bosse  A;  Zulch  A;  Becker  MB;  Torres  M;  Gomez-Skarmeta  JL;  Modolell  J;  Gruss  P:  Identification of the vertebrate Iroquois homeobox gene family with overlapping expression during early development of the nervous system.  Mech Dev 1997; 69:169—181
[CrossRef] | [PubMed]
 
Dear  TN;  Boehm  T:  Identification and characterization of two novel calpain large subunit genes.  Gene 2001; 274:245—252
[CrossRef] | [PubMed]
 
Ribon  V;  Printen  JA;  Hoffman  NG;  Kay  BK;  Saltiel  AR:  A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.  Mol Cell Biol 1998; 18:872—879
[PubMed]
 
Lebre  AS;  Jamot  L;  Takahashi  J;  Spassky  N;  Leprince  C;  Ravise  N;  Zander  C;  Fujigasaki  H;  Kussel-Andermann  P;  Duyckaerts  C;  Camonis  JH;  Brice  A:  Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions.  Hum Mol Genet 2001; 10:1201—1213
[CrossRef] | [PubMed]
 
Hodge  CW;  Raber  J;  McMahon  T;  Walter  H;  Sanchez-Perez  AM;  Olive  MF;  Mehmert  K;  Morrow  AL;  Messing  RO:  Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon.  J Clin Invest 2002; 110:1003—1010
[PubMed]
 
Shelton  RC;  Hal Manier  D;  Lewis  DA:  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.  Int J Neuropsychopharmacol 2009; 12:1223—1232
[CrossRef] | [PubMed]
 
Eichler  EE;  Flint  J;  Gibson  G;  Kong  A;  Leal  SM;  Moore  JH;  Nadeau  JH:  Missing heritability and strategies for finding the underlying causes of complex disease.  Nat Rev Genet 2010; 11:446—450
[CrossRef] | [PubMed]
 
Purcell  SM;  Wray  NR;  Stone  JL;  Visscher  PM;  O'Donovan  MC;  Sullivan  PF;  Sklar  P:  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.  Nature 2009; 460:748—752
[PubMed]
 
Mann  JJ;  Malone  KM;  Sweeney  JA;  Brown  RP;  Linnoila  M;  Stanley  B;  Stanley  M:  Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.  Neuropsychopharmacology 1996; 15:576—586
[CrossRef] | [PubMed]
 
Patsopoulos  NA;  Tatsioni  A;  Ioannidis  JP:  Claims of sex differences: an empirical assessment in genetic associations.  JAMA 2007; 298:880—893
[CrossRef] | [PubMed]
 
Cicho  n S;  Craddock  N;  Daly  M;  Faraone  SV;  Gejman  PV;  Kelsoe  J;  Lehner  T;  Levinson  DF;  Moran  A;  Sklar  P;  Sullivan  PF:  Genomewide association studies: history, rationale, and prospects for psychiatric disorders.  Am J Psychiatry 2009; 166:540—556
[CrossRef] | [PubMed]
 
References Container
Anchor for Jump
TABLE 1.

Mood Disorder Cohorts Included in Suicide Attempt Analyses

Anchor for Jump
TABLE 2.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Bipolar Disorder Discovery Cohort

Anchor for Jump
TABLE 3.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Major Depressive Disorder Discovery Cohort

Anchor for Jump
TABLE 4.

Gene-Based Tests of Association for 19 Candidate Loci

Anchor for Jump
TABLE 5.

Loci Showing Strongest Evidence of Association With Suicide Attempt in Meta-Analysis of All Mood Disorder Subjects

+

References

Osby  U;  Brandt  L;  Correia  N;  Ekbom  A;  Sparen  P:  Excess mortality in bipolar and unipolar disorder in Sweden.  Arch Gen Psychiatry 2001; 58:844—850
[CrossRef] | [PubMed]
 
Brodsky  BS;  Mann  JJ;  Stanley  B;  Tin  A;  Oquendo  M;  Birmaher  B;  Greenhill  L;  Kolko  D;  Zelazny  J;  Burke  AK;  Melhem  NM;  Brent  D:  Familial transmission of suicidal behavior: factors mediating the relationship between childhood abuse and offspring suicide attempts.  J Clin Psychiatry 2008; 69:584—596
[CrossRef] | [PubMed]
 
Brent  DA;  Bridge  J;  Johnson  BA;  Connolly  J:  Suicidal behavior runs in families: a controlled family study of adolescent suicide victims.  Arch Gen Psychiatry 1996; 53:1145—1152
[PubMed]
[CrossRef]
 
Johnson  BA;  Brent  DA;  Bridge  J;  Connolly  J:  The familial aggregation of adolescent suicide attempts.  Acta Psychiatr Scand 1998; 97:18—24
[CrossRef] | [PubMed]
 
Cheng  AT;  Chen  TH;  Chen  CC;  Jenkins  R:  Psychosocial and psychiatric risk factors for suicide: case-control psychological autopsy study.  Br J Psychiatry 2000; 177:360—365
[CrossRef] | [PubMed]
 
Schulze  TG;  Hedeker  D;  Zandi  P;  Rietschel  M;  McMahon  FJ:  What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics.  Arch Gen Psychiatry 2006; 63:1368—1376
[CrossRef] | [PubMed]
 
Fu  Q;  Heath  AC;  Bucholz  KK;  Nelson  EC;  Glowinski  AL;  Goldberg  J;  Lyons  MJ;  Tsuang  MT;  Jacob  T;  True  MR;  Eisen  SA:  A twin study of genetic and environmental influences on suicidality in men.  Psychol Med 2002; 32:11—24
[CrossRef] | [PubMed]
 
Statham  DJ;  Heath  AC;  Madden  PA;  Bucholz  KK;  Bierut  L;  Dinwiddie  SH;  Slutske  WS;  Dunne  MP;  Martin  NG:  Suicidal behaviour: an epidemiological and genetic study.  Psychol Med 1998; 28:839—855
[CrossRef] | [PubMed]
 
Wender  PH;  Kety  SS;  Rosenthal  D;  Schulsinger  F;  Ortmann  J;  Lunde  I:  Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders.  Arch Gen Psychiatry 1986; 43:923—929
[PubMed]
[CrossRef]
 
Liu  X;  Li  H;  Qin  W;  He  G;  Li  D;  Shen  Y;  Shen  J;  Gu  N;  Feng  G;  He  L:  Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population.  J Med Genet 2006; 43:e4
[CrossRef] | [PubMed]
 
Fukutake  M;  Hishimoto  A;  Nishiguchi  N;  Nushida  H;  Ueno  Y;  Shirakawa  O;  Maeda  K:  Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females.  Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1428—1433
[CrossRef] | [PubMed]
 
Yoon  HK;  Kim  YK:  TPH2-703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.  Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:403—409
[CrossRef] | [PubMed]
 
Bonnier  B;  Gorwood  P;  Hamon  M;  Sarfati  Y;  Boni  C;  Hardy-Bayle  MC:  Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk.  Biol Psychiatry 2002; 51:762—765
[CrossRef] | [PubMed]
 
Neves  FS;  Silveira  G;  Romano-Silva  MA;  Malloy-Diniz  L;  Ferreira  AA;  De Marco  L;  Correa  H:  Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients? Am J Med Genet B Neuropsychiatr Genet 2008; 147B:114—116
[CrossRef] | [PubMed]
 
Wasserman  D;  Wasserman  J;  Rozanov  V;  Sokolowski  M:  Depression in suicidal males: genetic risk variants in the CRHR1 gene.  Genes Brain Behav 2009; 8:72—79
[CrossRef] | [PubMed]
 
Willour  VL;  Chen  H;  Toolan  J;  Belmonte  P;  Cutler  DJ;  Goes  FS;  Zandi  PP;  Lee  RS;  MacKinnon  DF;  Mondimore  FM;  Schweizer  B;  Bipolar Disorder Phenome GroupNIMH Genetics Initiative Bipolar Disorder Consortium;  DePaulo  JR  Jr;  Gershon  ES;  McMahon  FJ;  Potash  JB:  Family-based association of FKBP5 in bipolar disorder.  Mol Psychiatry 2009; 14:261—268
[CrossRef] | [PubMed]
 
Sparks  DL;  Hunsaker  JC  3rd;  Amouyel  P;  Malafosse  A;  Bellivier  F;  Leboyer  M;  Courtet  P;  Helbecque  N:  Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors.  Am J Med Genet B Neuropsychiatr Genet 2009; 150B:290—294
[CrossRef] | [PubMed]
 
Must  A;  Tasa  G;  Lang  A;  Vasar  E;  Koks  S;  Maron  E;  Väli  M:  Association of limbic system-associated membrane protein (LSAMP) to male completed suicide.  BMC Med Genet 2008; 9:34
[CrossRef] | [PubMed]
 
Kohli  MA;  Salyakina  D;  Pfennig  A;  Lucae  S;  Horstmann  S;  Menke  A;  Kloiber  S;  Hennings  J;  Bradley  BB;  Ressler  KJ;  Uhr  M;  Müller-Myhsok  B;  Holsboer  F;  Binder  EB:  Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.  Arch Gen Psychiatry 2010; 67:348—359
[CrossRef] | [PubMed]
 
Kunugi  H;  Hashimoto  R;  Yoshida  M;  Tatsumi  M;  Kamijima  K:  A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide.  Am J Med Genet B Neuropsychiatr Genet 2004; 129B:44—46
[CrossRef] | [PubMed]
 
Lesch  KP;  Zeng  Y;  Reif  A;  Gutknecht  L:  Anxiety-related traits in mice with modified genes of the serotonergic pathway.  Eur J Pharmacol 2003; 480:185—204
[CrossRef] | [PubMed]
 
Brezo  J;  Klempan  T;  Turecki  G:  The genetics of suicide: a critical review of molecular studies.  Psychiatr Clin North Am 2008; 31:179—203
[CrossRef] | [PubMed]
 
Altshuler  D;  Daly  M:  Guilt beyond a reasonable doubt.  Nat Genet 2007; 39:813—815
[CrossRef] | [PubMed]
 
Ferreira  MA;  O'Donovan  MC;  Meng  YA;  Jones  IR;  Ruderfer  DM;  Jones  L;  Fan  J;  Kirov  G;  Perlis  RH;  Green  EK;  Smoller  JW;  Grozeva  D;  Stone  J;  Nikolov  I;  Chambert  K;  Hamshere  ML;  Nimgaonkar  VL;  Moskvina  V;  Thase  ME;  Caesar  S;  Sachs  GS;  Franklin  J;  Gordon-Smith  K;  Ardlie  KG;  Gabriel  SB;  Fraser  C;  Blumenstiel  B;  Defelice  M;  Breen  G;  Gill  M;  Morris  DW;  Elkin  A;  Muir  WJ;  Mc-Ghee  KA;  Williamson  R;  MacIntyre  DJ;  MacLean  AW;  Clair  D  St;  Robinson  M;  Van Beck  M;  Pereira  AC;  Kandaswamy  R;  McQuillin  A;  Collier  DA;  Bass  NJ;  Young  AH;  Lawrence  J;  Ferrier  IN;  Anjorin  A;  Farmer  A;  Curtis  D;  Scolnick  EM;  McGuffin  P;  Daly  MJ;  Corvin  AP;  Holmans  PA;  Blackwood  DH;  Gurling  HM;  Owen  MJ;  Purcell  SM;  Sklar  P;  Craddock  N; Wellcome Trust Case Control Consortium:  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.  Nat Genet 2008; 40:1056—1058
[CrossRef] | [PubMed]
 
Sachs  GS;  Thase  ME;  Otto  MW;  Bauer  M;  Miklowitz  D;  Wisniewski  SR;  Lavori  P;  Lebowitz  B;  Rudorfer  M;  Frank  E;  Nierenberg  AA;  Fava  M;  Bowden  C;  Ketter  T;  Marangell  L;  Calabrese  J;  Kupfer  D;  Rosenbaum  JF:  Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).  Biol Psychiatry 2003; 53:1028—1042
[CrossRef] | [PubMed]
 
Perlis  RH;  Ostacher  MJ;  Patel  JK;  Marangell  LB;  Zhang  H;  Wisniewski  SR;  Ketter  TA;  Miklowitz  DJ;  Otto  MW;  Gyulai  L;  Reilly-Harrington  NA;  Nierenberg  AA;  Sachs  GS;  Thase  ME:  Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar disorder (STEP-BD).  Am J Psychiatry 2006; 163:217—224
[CrossRef] | [PubMed]
 
Wellcome Trust Case Control Consortium:  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.  Nature 2007; 447:661—678
[CrossRef] | [PubMed]
 
Li  Y;  Abecasis  G:  MACH 1.0:  Rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet 2006; S79:2290
 
Smith  EN;  Bloss  CS;  Badner  JA;  Barrett  T;  Belmonte  PL;  Berrettini  W;  Byerley  W;  Coryell  W;  Craig  D;  Edenberg  HJ;  Eskin  E;  Foroud  T;  Gershon  E;  Greenwood  TA;  Hipolito  M;  Koller  DL;  Lawson  WB;  Liu  C;  Lohoff  F;  McInnis  MG;  McMahon  FJ;  Mirel  DB;  Murray  SS;  Nievergelt  C;  Nurnberger  J;  Nwulia  EA;  Paschall  J;  Potash  JB;  Rice  J;  Schulze  TG;  Scheftner  W;  Panganiban  C;  Zaitlen  N;  Zandi  PP;  Zöllner  S;  Schork  NJ;  Kelsoe  JR:  Genome-wide association study of bipolar disorder in European American and African American individuals.  Mol Psychiatry 2009; 14:755—763
[CrossRef] | [PubMed]
 
NIMH Genetics Bipolar Group:  Genomic survey of bipolar illness in the NIMH Genetics Initiative pedigrees: a preliminary report.  Am J Med Genet 1997; 74:227—237
[CrossRef] | [PubMed]
 
McMahon  FJ;  Akula  N;  Schulze  TG;  Muglia  P;  Tozzi  F;  Detera-Wadleigh  SD;  Steele  CJ;  Breuer  R;  Strohmaier  J;  Wendland  JR;  Mattheisen  M;  Mühleisen  TW;  Maier  W;  Nöthen  MM;  Cichon  S;  Farmer  A;  Vincent  JB;  Holsboer  F;  Preisig  M;  Rietschel  M; Bipolar Disorder Genome Study Consortium:  Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1.  Nat Genet 2010; 42:128—131
[CrossRef] | [PubMed]
 
Rush  AJ;  Fava  M;  Wisniewski  SR;  Lavori  PW;  Trivedi  MH;  Sackeim  HA;  Thase  ME;  Nierenberg  AA;  Quitkin  FM;  Kashner  TM;  Kupfer  DJ;  Rosenbaum  JF;  Alpert  J;  Stewart  JW;  McGrath  PJ;  Biggs  MM;  Shores-Wilson  K;  Lebowitz  BD;  Ritz  L;  Niederehe  G; STAR*D Investigators Group:  Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design.  Control Clin Trials 2004; 25:119—142
[CrossRef] | [PubMed]
 
Penninx  BW;  Beekman  AT;  Smit  JH;  Zitman  FG;  Nolen  WA;  Spin-hoven  P;  Cuijpers  P;  De Jong  PJ;  Van Marwijk  HW;  Assendelft  WJ;  Van Der Meer  K;  Verhaak  P;  Wensing  M;  De Graaf  R;  Hoogendijk  WJ;  Ormel  J;  Van Dyck  R; NESDA Research Consortium:  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.  Int J Methods Psychiatr Res 2008; 17:121—140
[CrossRef] | [PubMed]
 
Boomsma  DI;  de Geus  EJ;  Vink  JM;  Stubbe  JH;  Distel  MA;  Hottenga  JJ;  Posthuma  D;  van Beijsterveldt  TC;  Hudziak  JJ;  Bartels  M;  Willemsen  G:  Netherlands Twin Register: from twins to twin families.  Twin Res Hum Genet 2006; 9:849—857
[CrossRef] | [PubMed]
 
Sullivan  PF;  de Geus  EJ;  Willemsen  G;  James  MR;  Smit  JH;  Zand-belt  T;  Arolt  V;  Baune  BT;  Blackwood  D;  Cichon  S;  Coventry  WL;  Domschke  K;  Farmer  A;  Fava  M;  Gordon  SD;  He  Q;  Heath  AC;  Heutink  P;  Holsboer  F;  Hoogendijk  WJ;  Hottenga  JJ;  Hu  Y;  Kohli  M;  Lin  D;  Lucae  S;  MacIntyre  DJ;  Maier  W;  McGhee  KA;  McGuffin  P;  Montgomery  GW;  Muir  WJ;  Nolen  WA;  Nöthen  MM;  Perlis  RH;  Pirlo  K;  Posthuma  D;  Rietschel  M;  Rizzu  P;  Schosser  A;  Smit  AB;  Smoller  JW;  Tzeng  JY;  van Dyck  R;  Verhage  M;  Zitman  FG;  Martin  NG;  Wray  NR;  Boomsma  DI;  Penninx  BW:  Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.  Mol Psychiatry 2009; 14:359—375
[CrossRef] | [PubMed]
 
Garriock  HA;  Kraft  JB;  Shyn  SI;  Peters  EJ;  Yokoyama  JS;  Jenkins  GD;  Reinalda  MS;  Slager  SL;  McGrath  PJ;  Hamilton  SP:  A genomewide association study of citalopram response in major depressive disorder.  Biol Psychiatry 2010; 15:133—138
[CrossRef]
 
Sachs  GS;  Guille  C;  McMurrich  SL:  A clinical monitoring form for mood disorders.  Bipolar Disord 2002; 4:323—327
[CrossRef] | [PubMed]
 
First  MB;  Spitzer  R;  Gibbon  M:  Structured Clinical Interview for DSM-IV Axis I Disorders.  New York,  Biometrics Research Department, New York State Psychiatric Institute, 1996
 
Endicott  J;  Spitzer  RL:  A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia.  Arch Gen Psychiatry 1978; 35:837—844
[PubMed]
[CrossRef]
 
Nurnberger  JI  Jr;  Blehar  MC;  Kaufmann  CA;  York-Cooler  C;  Simpson  SG;  Harkavy-Friedman  J;  Severe  JB;  Malaspina  D;  Reich  T:  Diagnostic Interview for Genetic Studies: rationale, unique features, and training: NIMH Genetics Initiative.  Arch Gen Psychiatry 1994; 51:849—859; discussion 63-64
[PubMed]
[CrossRef]
 
Rush  AJ;  Trivedi  MH;  Ibrahim  HM;  Carmody  TJ;  Arnow  B;  Klein  DN;  Markowitz  JC;  Ninan  PT;  Kornstein  S;  Manber  R;  Thase  ME;  Kocsis  JH;  Keller  MB:  The 16-item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.  Biol Psychiatry 2003; 54:573—583
[CrossRef] | [PubMed]
 
World Health Organization:  Composite International Diagnostic Interview (CIDI), version 2.1.  Geneva, Switzerland,  World Health Organization, 1997
 
Purcell  S;  Neale  B;  Todd-Brown  K;  Thomas  L;  Ferreira  MA;  Bender  D;  Maller  J;  Sklar  P;  de Bakker  PI;  Daly  MJ;  Sham  PC:  PLINK: a tool set for whole-genome association and population-based linkage analyses.  Am J Hum Genet 2007; 81:559—575
[CrossRef] | [PubMed]
 
Makambi  KH:  Weighted inverse chi-square method for correlated significance tests.  J Appl Stat 2003; 30:225—234
[CrossRef]
 
Matsuda  S;  Iriyama  C;  Yokozaki  S;  Ichigotani  Y;  Shirafuji  N;  Yamaki  K;  Senba  M;  Uezato  H;  Ohshima  K;  Duc Dodon  M;  Wu  KJ;  Mori  N:  Cloning and sequencing of a novel human gene that encodes a putative target protein of NESH-SH3.  J Hum Genet 2001; 46:483—486
[CrossRef] | [PubMed]
 
Wakoh  T;  Sugimoto  M;  Terauchi  K;  Shimada  J;  Maruyama  M:  A novel p53-dependent apoptosis function of TARSH in tumor development.  Nagoya J Med Sci 2009; 71:109—114
[PubMed]
 
Latini  FR;  Hemerly  JP;  Oler  G;  Riggins  GJ;  Cerutti  JM:  Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.  Endocr Relat Cancer 2008; 15:787—799
[CrossRef] | [PubMed]
 
Uekawa  N;  Terauchi  K;  Nishikimi  A;  Shimada  J;  Maruyama  M:  Expression of TARSH gene in MEFS senescence and its potential implication in human lung cancer.  Biochem Biophys Res Commun 2005; 329:1031—1038
[CrossRef] | [PubMed]
 
Shirakabe  K;  Priori  G;  Yamada  H;  Ando  H;  Horita  S;  Fujita  T;  Fujimoto  I;  Mizutani  A;  Seki  G;  Mikoshiba  K:  IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na+/HCO3-cotransporter 1 (pNBC1).  Proc Natl Acad Sci U S A 2006; 103:9542—9547
[CrossRef] | [PubMed]
 
Itano  N;  Kimata  K:  Molecular cloning of human hyaluronan synthase.  Biochem Biophys Res Commun 1996; 222:816—820
[CrossRef] | [PubMed]
 
Al'Qteishat  A;  Gaffney  J;  Krupinski  J;  Rubio  F;  West  D;  Kumar  S;  Kumar  P;  Mitsios  N;  Slevin  M:  Changes in hyaluronan production and metabolism following ischaemic stroke in man.  Brain 2006; 129:2158—2176
[CrossRef] | [PubMed]
 
Turpaev  K;  Glatigny  A;  Bignon  J;  Delacroix  H;  Drapier  JC:  Variation in gene expression profiles of human monocytic U937 cells exposed to various fluxes of nitric oxide.  Free Radic Biol Med 2010; 48:298—305
[CrossRef] | [PubMed]
 
Strausberg  RL;  Feingold  EA;  Grouse  LH;  Derge  JG;  Klausner  RD;  Collins  FS;  Wagner  L;  Shenmen  CM;  Schuler  GD;  Altschul  SF;  Zeeberg  B;  Buetow  KH;  Schaefer  CF;  Bhat  NK;  Hopkins  RF;  Jordan  H;  Moore  T;  Max  SI;  Wang  J;  Hsieh  F;  Diatchenko  L;  Marusina  K;  Farmer  AA;  Rubin  GM;  Hong  L;  Stapleton  M;  Soares  MB;  Bonaldo  MF;  Casavant  TL;  Scheetz  TE;  Brownstein  MJ;  Usdin  TB;  Toshiyuki  S;  Carninci  P;  Prange  C;  Raha  SS;  Loquellano  NA;  Peters  GJ;  Abramson  RD;  Mullahy  SJ;  Bosak  SA;  McEwan  PJ;  McKernan  KJ;  Malek  JA;  Gunaratne  PH;  Richards  S;  Worley  KC;  Hale  S;  Garcia  AM;  Gay  LJ;  Hulyk  SW;  Villalon  DK;  Muzny  DM;  Sodergren  EJ;  Lu  X;  Gibbs  RA;  Fahey  J;  Helton  E;  Ketteman  M;  Madan  A;  Rodrigues  S;  Sanchez  A;  Whiting  M;  Madan  A;  Young  AC;  Shevchenko  Y;  Bouffard  GG;  Blakesley  RW;  Touchman  JW;  Green  ED;  Dickson  MC;  Rodriguez  AC;  Grim-wood  J;  Schmutz  J;  Myers  RM;  Butterfield  YS;  Krzywinski  MI;  Skalska  U;  Smailus  DE;  Schnerch  A;  Schein  JE;  Jones  SJ;  Marra  MA; Mammalian Gene Collection Program Team:  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.  Proc Natl Acad Sci U S A 2002; 99:16899—16903
[CrossRef] | [PubMed]
 
Yoon  HG;  Chan  DW;  Huang  ZQ;  Li  J;  Fondell  JD;  Qin  J;  Wong  J:  Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.  EMBO J 2003; 22:1336—1346
[CrossRef] | [PubMed]
 
Bosse  A;  Zulch  A;  Becker  MB;  Torres  M;  Gomez-Skarmeta  JL;  Modolell  J;  Gruss  P:  Identification of the vertebrate Iroquois homeobox gene family with overlapping expression during early development of the nervous system.  Mech Dev 1997; 69:169—181
[CrossRef] | [PubMed]
 
Dear  TN;  Boehm  T:  Identification and characterization of two novel calpain large subunit genes.  Gene 2001; 274:245—252
[CrossRef] | [PubMed]
 
Ribon  V;  Printen  JA;  Hoffman  NG;  Kay  BK;  Saltiel  AR:  A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes.  Mol Cell Biol 1998; 18:872—879
[PubMed]
 
Lebre  AS;  Jamot  L;  Takahashi  J;  Spassky  N;  Leprince  C;  Ravise  N;  Zander  C;  Fujigasaki  H;  Kussel-Andermann  P;  Duyckaerts  C;  Camonis  JH;  Brice  A:  Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions.  Hum Mol Genet 2001; 10:1201—1213
[CrossRef] | [PubMed]
 
Hodge  CW;  Raber  J;  McMahon  T;  Walter  H;  Sanchez-Perez  AM;  Olive  MF;  Mehmert  K;  Morrow  AL;  Messing  RO:  Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon.  J Clin Invest 2002; 110:1003—1010
[PubMed]
 
Shelton  RC;  Hal Manier  D;  Lewis  DA:  Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.  Int J Neuropsychopharmacol 2009; 12:1223—1232
[CrossRef] | [PubMed]
 
Eichler  EE;  Flint  J;  Gibson  G;  Kong  A;  Leal  SM;  Moore  JH;  Nadeau  JH:  Missing heritability and strategies for finding the underlying causes of complex disease.  Nat Rev Genet 2010; 11:446—450
[CrossRef] | [PubMed]
 
Purcell  SM;  Wray  NR;  Stone  JL;  Visscher  PM;  O'Donovan  MC;  Sullivan  PF;  Sklar  P:  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.  Nature 2009; 460:748—752
[PubMed]
 
Mann  JJ;  Malone  KM;  Sweeney  JA;  Brown  RP;  Linnoila  M;  Stanley  B;  Stanley  M:  Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.  Neuropsychopharmacology 1996; 15:576—586
[CrossRef] | [PubMed]
 
Patsopoulos  NA;  Tatsioni  A;  Ioannidis  JP:  Claims of sex differences: an empirical assessment in genetic associations.  JAMA 2007; 298:880—893
[CrossRef] | [PubMed]
 
Cicho  n S;  Craddock  N;  Daly  M;  Faraone  SV;  Gejman  PV;  Kelsoe  J;  Lehner  T;  Levinson  DF;  Moran  A;  Sklar  P;  Sullivan  PF:  Genomewide association studies: history, rationale, and prospects for psychiatric disorders.  Am J Psychiatry 2009; 166:540—556
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 25

Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 6.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 45.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 3.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles